breakthrough technology to treat localized cancer tumors

LIPAC Oncology is a clinical-stage drug delivery company focused on developing unique localized therapies to treat cancer in challenging parts of the body. It’s breakthrough technology addresses shortcomings of current treatments for Bladder Cancer, Upper Tract Urothelial Carcinoma and Stage II/III Ovarian Cancer.



Find out about our organization, team, and the results of our decades of research and development.

Learn More →


Explore the pipeline of new products we are developing and taking into the clinic

Learn More →